Effect of preoperative moderate-dose statin and duration on acute kidney injury after cardiac surgery: a retrospective cohort study

被引:0
作者
Jiang, Jicheng [1 ]
Liu, Xinyun [1 ]
Cheng, Zhaoyun [2 ,3 ]
Liu, Qianjin [2 ]
Xing, Wenlu [1 ]
机构
[1] Zhengzhou Univ, Cent China Fuwai Hosp, Henan Prov Peoples Hosp, Dept Big Data Ctr Cardiovasc Dis, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Cent China Fuwai Hosp, Henan Prov Peoples Hosp, Dept Cardiovasc Surg, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Cent China Fuwai Hosp, Henan Prov Peoples Hosp, Dept Cardiovasc Surg, 1 Fuwai Ave, Zhengzhou, Peoples R China
关键词
Acute kidney injury; cardiac surgery; statin; C-REACTIVE PROTEIN; ROSUVASTATIN PHARMACOKINETICS; ATRIAL-FIBRILLATION; ADULT PATIENTS; METAANALYSIS; ATORVASTATIN; PREVENTION; THERAPY; RISK; PHARMACOGENETICS;
D O I
10.1080/03007995.2023.2286317
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The impact of preoperative statin use on postoperative acute kidney injury (AKI) is uncertain. We aimed to examine the association of statin therapy before cardiac surgery with postoperative AKI.Methods: The retrospective cohort study consisted of 1581 patients undergoing cardiac surgery. Postoperative AKI were identified by the modified KDIGO definition. Propensity-score matching was employed to control for selection bias, and logistic regression was used to control for confounders. Subgroup and interaction analyses were performed to evaluate the robustness of the findings.Results: The overall incidence of postoperative AKI and severe AKI were 42.19% and 12.27%, respectively. Preoperative moderate-dose statin was significantly associated with a reduced incidence of postoperative AKI (28.9% vs 43.0%, OR (95%CI): 0.54 (0.38, 0.77), p < 0.001) and severe AKI (6.9% vs 13.7%, OR (95%CI): 0.46 (0.26, 0.83), p = 0.009). The beneficial effect on postoperative AKI persisted after adjusting for major confounding factors (OR (95%CI): 0.47 (0.34, 0.66)). Decreased risk of postoperative AKI was observed in patients with preoperative statin duration of 7 similar to 14 days (OR (95%CI): 0.41 (0.25, 0.65)) and over 14 days (OR (95%CI): 0.43 (0.28, 0.65)), but not in those with preoperative statin duration of <7 days. Similar favorable effects were noted in most subgroup patients, except for those with high-risk factors such as diabetes mellitus, previous congestive cardiac failure, arrhythmia, preoperative ACEI/ARB, aortic cross-clamping or IABP.Conclusion: Preoperative moderate-dose statin was significantly related to a decreased risk of postoperative AKI, especially in patients who received statins for a longer duration. Further large-scale multicenter randomized controlled trials are needed to ascertain the impact of statin dose, duration, and timing on postoperative AKI in cardiac surgery patients.
引用
收藏
页码:229 / 238
页数:10
相关论文
共 53 条
  • [1] Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
    Adam, Oliver
    Neuberger, Hans-Ruprecht
    Boehm, Michael
    Laufs, Ulrich
    [J]. CIRCULATION, 2008, 118 (12) : 1285 - 1293
  • [2] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
    Albert, MA
    Danielson, E
    Rifai, N
    Ridker, PM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01): : 64 - 70
  • [3] Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer - Insights from large randomized statin trials
    Alsheikh-Ali, Alawi A.
    Maddukuri, Prasad V.
    Han, Hui
    Karas, Richard H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (05) : 409 - 418
  • [4] The effect of preoperative statins on postoperative mortality, renal, and neurological complications in patients undergoing cardiac surgeries: a retrospective cohort study
    Astaneh, Behrooz
    Nemati, Mohammad H.
    Shahraki, Hadi Raeisi
    Bijari, Kezhal
    Astaneh, Vala
    Cook, Deborah
    Levine, Mitchell
    [J]. JOURNAL OF CARDIOVASCULAR SURGERY, 2023, 64 (01) : 100 - 111
  • [5] High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery A Randomized Clinical Trial
    Billings, Frederic T.
    Hendricks, Patricia A.
    Schildcrout, Jonathan S.
    Shi, Yaping
    Petracek, Michael R.
    Byrne, John G.
    Brown, Nancy J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (09): : 877 - 888
  • [6] Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States
    Birmingham, Bruce K.
    Bujac, Sarah R.
    Elsby, Robert
    Azumaya, Connie T.
    Zalikowski, Julie
    Chen, Yusong
    Kim, Kenneth
    Ambrose, Helen J.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (03) : 329 - 340
  • [7] Preoperative Statins and Acute Kidney Injury After Cardiac Surgery: Utilization of a Consensus Definition of Acute Kidney Injury
    Bolesta, Scott
    Uhrin, Lindsey M.
    Guzek, John R.
    [J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (01) : 23 - 30
  • [8] Cardiopulmonary Bypass-Induced Inflammatory Response: Pathophysiology and Treatment
    Bronicki, Ronald A.
    Hall, Mark
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2016, 17 (08) : S272 - S278
  • [9] Effect of statins on atrial fibrillation after cardiac surgery: A duration- and dose-response meta-analysis
    Chen, Wendy T.
    Krishnan, Guru M.
    Sood, Nitesh
    Kluger, Jeffrey
    Coleman, Craig I.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 140 (02) : 364 - 372
  • [10] Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis
    Coca, Steven G.
    Singanamala, Swathi
    Parikh, Chirag R.
    [J]. KIDNEY INTERNATIONAL, 2012, 81 (05) : 442 - 448